Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

BENNY R MRNUSTIK

Allopathic & Osteopathic Physicians Family Medicine

NPI
1093773558
CMS profile
95354
Location
ROWLETT, TX

General Payments · PY2018–2020

$3,906.67

  • Reported across 309 records
  • CMS publication 2026-01-23

Latest program year · PY2020

$227.71

15 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2020 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $227.71 15

By paying entity

PY2020 · sorted by reported total

Paying entityAmountRecords
Amgen Inc. $69.07 4
Novo Nordisk AS $55.12 4
Acerta Pharma LLC $25.07 2
Allergan Inc. $24.89 1
Genentech USA, Inc. $14.50 1
Boehringer Ingelheim Pharmaceuticals, Inc. $13.55 1
IRONSHORE PHARMACEUTICALS INC. $13.44 1
Lilly USA, LLC $12.07 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $2,030.89 178
PY2019 $1,648.07 116
PY2020 $227.71 15

Payment records · PY2020 (15)

Sorted by paying entity, then date · as published by CMS

Program year 2020 20182019 Record-level detail is published for PY2020; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
Allergan, Inc. $24.89 04/06/2020 Food and Beverage Undisputed 01/23/2026 723731277 CMS
Amgen Inc. $16.70 01/21/2020 Food and Beverage Undisputed 01/23/2026 740931103 CMS
Amgen Inc. $17.98 01/21/2020 Food and Beverage Undisputed 01/23/2026 740931107 CMS
Amgen Inc. $22.40 01/29/2020 Food and Beverage Undisputed 01/23/2026 740931111 CMS
Amgen Inc. $11.99 03/11/2020 Food and Beverage Undisputed 01/23/2026 740931115 CMS
AstraZeneca Pharmaceuticals LP $14.00 01/09/2020 Food and Beverage Undisputed 01/23/2026 736397689 CMS
AstraZeneca Pharmaceuticals LP $11.07 03/05/2020 Food and Beverage Undisputed 01/23/2026 735998445 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $13.55 02/03/2020 Food and Beverage Undisputed 01/23/2026 720504299 CMS
Genentech USA, Inc. $14.50 02/19/2020 Food and Beverage Undisputed 01/23/2026 742988857 CMS
Ironshore Pharmaceuticals Inc. $13.44 01/27/2020 Food and Beverage Undisputed 01/23/2026 737025685 CMS
Lilly USA, LLC $12.07 02/26/2020 Food and Beverage Undisputed 01/23/2026 728362709 CMS
Novo Nordisk Inc $16.77 01/06/2020 Food and Beverage Undisputed 01/23/2026 744560065 CMS
Novo Nordisk Inc $15.68 01/23/2020 Food and Beverage Undisputed 01/23/2026 744575357 CMS
Novo Nordisk Inc $11.10 02/06/2020 Food and Beverage Undisputed 01/23/2026 744617533 CMS
Novo Nordisk Inc $11.57 03/03/2020 Food and Beverage Undisputed 01/23/2026 744653413 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020
Generated from
OP_DTL_GNRL_PGYR2020_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.